Literature DB >> 12354987

Prostate: high-frequency Doppler US imaging for cancer detection.

Ethan J Halpern1, Ferdinand Frauscher, Stephen E Strup, Levon N Nazarian, Patrick O'Kane, Leonard G Gomella.   

Abstract

PURPOSE: To evaluate cancer detection with targeted biopsy of the prostate performed on the basis of high-frequency Doppler ultrasonographic (US) imaging findings versus cancer detection with a modified sextant biopsy approach with laterally directed cores.
MATERIALS AND METHODS: Sixty-two patients were prospectively evaluated with gray-scale, color, and power Doppler transrectal US performed with patients in the lithotomy position. Gray-scale and Doppler findings within each sextant were rated on a five-point scale. Up to four targeted biopsy specimens were obtained from each patient on the basis of Doppler findings; this was followed by a modified sextant biopsy. Conditional logistic regression analysis was performed to compare the positive yields for targeted and sextant biopsy specimens. Clustered receiver operating characteristic analysis was performed to compare gray-scale, color, and power Doppler detection of cancer at sextant biopsy sites.
RESULTS: Cancer was detected in 18 (29%) of 62 patients, including 11 patients in whom cancer was detected with both sextant and targeted biopsy, six in whom cancer was detected only with sextant biopsy, and one in whom cancer was detected only with targeted biopsy. The positive biopsy rate for targeted biopsy (24 [13%] of 185 cores) was slightly higher than that for sextant biopsy (36 [9.7%] of 372 cores; P =.1). The odds ratio for cancer detection with targeted versus sextant cores was 1.8 (95% CI: 0.9, 3.7). Receiver operating characteristic analysis demonstrated that overall identification of positive sextant biopsy sites was close to random chance for gray-scale (area under the curve, 0.53), color Doppler (area under the curve, 0.50), and power Doppler (area under the curve, 0.47) imaging.
CONCLUSION: Targeted biopsy performed on the basis of high-frequency color or power Doppler findings will miss a substantial number of cancers detected with sextant biopsy.

Entities:  

Mesh:

Year:  2002        PMID: 12354987     DOI: 10.1148/radiol.2251011938

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  19 in total

Review 1.  Methods for volume assessment of prostate cancer.

Authors:  Heinz-Peter Schlemmer; Stefan Corvin
Journal:  Eur Radiol       Date:  2004-02-06       Impact factor: 5.315

Review 2.  A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer.

Authors:  Stijn W T P J Heijmink; Hilco van Moerkerk; Lambertus A L M Kiemeney; J Alfred Witjes; Ferdinand Frauscher; Jelle O Barentsz
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

3.  Contrast-enhanced ultrasound imaging of prostate cancer.

Authors:  Ethan J Halpern
Journal:  Rev Urol       Date:  2006

4.  Magnetic resonance imaging and spectroscopy of prostate cancer.

Authors:  Peter R Carroll; Fergus V Coakley; John Kurhanewicz
Journal:  Rev Urol       Date:  2006

5.  MR-compatible assistance system for punction in a high-field system: device and feasibility of transgluteal biopsies of the prostate gland.

Authors:  Stephan Zangos; Christopher Herzog; Katrin Eichler; Renate Hammerstingl; Andreas Lukoschek; Stefanie Guthmann; Bernd Gutmann; Uwe Joseph Schoepf; Phillip Costello; Thomas J Vogl
Journal:  Eur Radiol       Date:  2006-10-10       Impact factor: 5.315

6.  Transrectal real-time elastography-guided transperineal prostate biopsy as an improved tool for prostate cancer diagnosis.

Authors:  Ren Wang; Jin-Jin Chen; Bing Hu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

7.  A new 5-grading score in the diagnosis of prostate cancer with real-time elastography.

Authors:  Guang Xu; Lijing Feng; Minghua Yao; Jian Wu; Lehang Guo; Xudong Yao; Lixia Zhao; Huixiong Xu; Rong Wu
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

8.  The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: the Beth Israel Deaconess Medical Center (BIDMC) approach.

Authors:  B Nicolas Bloch; Robert E Lenkinski; Neil M Rofsky
Journal:  Cancer Biomark       Date:  2008       Impact factor: 4.388

9.  MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results.

Authors:  Stephan Zangos; Katrin Eichler; Kerstin Engelmann; Mukhtiar Ahmed; Sebastian Dettmer; Christopher Herzog; Wasilios Pegios; A Wetter; Thomas Lehnert; Martin G Mack; Thomas J Vogl
Journal:  Eur Radiol       Date:  2004-09-04       Impact factor: 5.315

Review 10.  Transrectal contrast enhanced ultrasound for diagnosis of prostate cancer.

Authors:  M H Wink; J J M C H de la Rosette; C A Grimbergen; H Wijkstra
Journal:  World J Urol       Date:  2007-06-27       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.